The Uganda Population-based HIV Impact Assessment (UPHIA 2020-2021) was a national household-based survey among adults (defined as individuals aged 15 years and older) to measure the impact of the national HIV response. Conducted from February 2020 through March 2021 (with a pause from March 2020 until October 2020 due to the COVID-19 pandemic), UPHIA 2020-2021 offered HIV counseling and testing with return of results and collected information about uptake of HIV care and treatment services.
UPHIA 2020-2021 was the second UPHIA to estimate national HIV incidence and the national and district-level prevalence of HIV and viral load suppression, defined as HIV RNA <1,000 copies per milliliter. The first UPHIA was conducted from August 2016 through March 2017. The results of these two surveys provide critical information about national and district-level progress toward control of the HIV epidemic.
This project is supported by the US President’s Emergency Plan for AIDS Relief (PEPFAR) through CDC under the terms of cooperative agreement #U2GGH002173. The findings and conclusions are those of the authors and do not necessarily represent the official position of the funding agencies.
Update on Drug Resistance Data Availability: The PHIA 2 Final Reports initially noted that drug resistance (DR) data would be forthcoming. DR data is now available through the public use data package for approved researchers. For access to Uganda’s DR tables and further details, please visit the data set section of the PHIA website.
